Background. Patients with cluster headache tend to have a dysregulation of systemic blood pressure such as increased blood pressure variability and decreased nocturnal dipping. This pattern of nocturnal nondipping is associated with end-organ damage and increased risk of cardiovascular disease.
Introduction
It has been suggested that there is an association between cluster headache (CH) and obstructive sleep apnea (OSA) [1] [2] [3] , and cross-sectional studies have shown that moderate to severe OSA is a risk factor for developing hypertension [4] . The absence of normal decreases (10% to 20%) in nocturnal blood pressure (BP), known as nocturnal dipping, is a strong and independent predictor of cardiovascular risk. In a previous study, we showed that patients with CH trend to present a dysregulated systemic BP in the form of increased variability and decreased nocturnal dipping [5] . In normotensive patients, the prevalence of nondippers has been estimated to range from 18% to 20% [6, 7] . By contrast, among patients with OSA, 48% to 84% of patients are nondippers, with the rate increasing as a function of OSA severity [8, 9] . We previously reported a higher incidence (50%) of nondipping in CH patients [5] . The fact that the incidence rate of nondipping tested by 24-hour ambulatory blood pressure monitoring (ABMP) is higher than expected in both pathologies supports the hypothesis of its association.
The presence of the nondipping pattern might be associated with end-organ damage (left ventricular or funduscopic changes) and increase the risk (up to 50% higher) for cardiovascular disease (CVD) [10] . Given this context, the aim of the present study was to determine if patients with episodic CH present a higher risk of CVD.
Methods

Subjects
Thirty-three consecutive episodic CH patients from the Headache Unit at our tertiary care center and 30 ageand gender-matched healthy controls were recruited between 2011 and 2013. Of these 33 CH patients, 13 had participated in our previous study [5] . All participants were enrolled in the study in accordance with the inclusion and exclusion criteria stipulated in the study protocol: None of the participants were receiving treatment for any previously diagnosed cardiovascular risk factors (CRF; hypertension, dyslipidemia, and diabetes) [11] , and all patients were outside the cluster bouts. Prior to enrollment, all subjects were asked to provide written informed consent to participate.
Episodic CH was diagnosed according to the International Classification of Headache Disorders, 3rd edition (beta version) [12] . The following variables were assessed: age, sex, height, weight, body mass index (BMI), and previous diagnoses of OSA. Patients with BMI 30 kg/m 2 or 25 kg/m 2 were classified as, respectively, obese or overweight.
Although smoking is an important risk factor for vascular disease, smoking status was not an exclusion criterion in our study, given that the reported prevalence of smokers among patients with CH is up to 65% [13] . Smoking status was ascertained by a self-report questionnaire (nonsmoker, former smoker, or current smoker). For the purpose of the present study, ''eversmoker'' status (former or current) was used.
Physical and neurological examinations were unremarkable in all subjects. All participants underwent 24-hour ambulatory blood pressure monitoring using a noninvasive portable validated recorder (SpaceLab 90207; Spacelabs Medical, Redmond, WA, USA) to measure nocturnal BP dipping. A BP cuff was fitted to the nondominant arm of the patient. We defined daytime as the time interval ranging from 9:00 to 23:00 hours. The corresponding nighttime interval ranged from 23:00 to 9:00. BP readings were obtained at 20-minute intervals and averaged for subsequent analysis. The patients were instructed not to change their usual sleep-wake cycle and scheduled activities. The time of the application (61 hour) was the same for all patients (in the morning). The BP study was considered adequate when at least 80% of the measurements were error free. The recorder automatically discarded false readings. A decrease of 10% to 20% in mean nocturnal BP (both systolic and diastolic) compared with mean daytime BP is considered normal. Conversely, a less than 10% decrease in nocturnal BP is considered to represent an absence of nocturnal dipping (i.e., nondipping).
We also assessed various predictors of risk for CVD, including anthropometric, hematologic (lipid and nonlipid biomarkers), and structural parameters (carotid intimamedia thickness [IMT] and ankle-brachial pressure index [ABI]). The study was conducted in complete accordance with the Declaration of Helsinki.
Laboratory Parameters
Venous blood was drawn in the morning after an overnight fast. Complete blood cell counts, serum electrolytes, and thyroid function tests were within the normal range of standardized values in all the participants. The following vascular risk predictors [14] 
Structural Parameters
Arterial stiffness has been known to play a substantial role in the development of CVD through the process of atherosclerosis. This stiffness can be noninvasively measured with the ABI and the IMT indices.
Carotid duplex ultrasonography was performed using a HITACHI eub-6500 ultrasound to measure IMT and carotid plaques. IMT was measured at the far wall of each common carotid artery. A region located 1 cm proximally to the bulb was first identified, and the measurements were made at five continuous sites separated by approximately 1 cm. The value of the thickest was used as the study variable. Plaques were defined as focal structures that encroached upon the arterial lumen by at 0.5 mm or greater or 50% of the surrounding IMT. When a plaque was present, IMT was measured at the nearest plaque-free point. The value of the IMT was defined as the mean value of measurements between the right and left carotid arteries [15] . IMT values were established according to a percentile distribution (5th, 10th, 25th, 75th, 90th, 95th) of the mean carotid artery IMT in individuals without CRF and stratified by age and sex [16] .
The ABI is the ratio between the ankle and the brachial systolic blood pressure. An ABI value of less than 0.90 indicates the presence of flow-limiting arterial disease affecting the limb. The ABI is used to diagnose peripheral arterial disease peripheral arterial disease (PAD) of the lower extremities in symptomatic patients and to assess vascular risk in asymptomatic patients. Recently, ABI values of 1.30 or greater have been associated with arterial calcification and wall stiffening. In the present study, ABI was measured using an automated analyzer TWIN200. Subjects are asked to lie on their back to rest for five minutes, after which cuffs containing sensors with record pulse wave generated from brachial and tibial arteries are wrapped around the upper arms and ankles. The ABI is calculated as the ratio of the systolic blood pressure in the ankles to the systolic pressure in arms. We used cutoff points of 0.9 or less and 1.29 or greater as the normal range for ABI [17] .
Statistical Analysis
For statistical analysis, we used SPSS version 15.0 (SPSS Inc., Chicago, IL, USA). Blood marker data and BMI and ABI values were expressed as the means 6 standard deviation. Differences between groups were compared by the chi-square test for categorical variables and by the t test for continuous variables. A P value of 0.05 or less was considered statistically significant.
Results
The main characteristics of the two groups are shown in , P ¼ 0.042). In the CH group, one patient had a previous diagnosis of OSA whereas none of the controls had OSA. Based on the 24-hour BP monitoring, physiological nocturnal dipping in arterial BP was present in 17 of the CH patients while the remaining 16 patients (48.5%) had a nondipping pattern. By contrast, only found five subjects (16.6%) in the control group presented a nondipping pattern (P ¼ 0.004). In terms of the various predictors of vascular risk, the mean laboratory results showed a nonsignificant trend toward abnormal values in CH group. By contrast, no pathological values were observed in the healthy control group. We found no significant association between laboratory and structural parameters, with the exception of TG and homocysteine.
As Table 2 shows, the pattern of nocturnal nondipping in the episodic CH group was associated with the following variables: higher BMI (P ¼ 0.02), pathological ABI values (pABI; P ¼ 0.017), and a carotid IMT cutoff point at the 75th percentile (P ¼ 0.04). No significant differences were observed in the mean 24-hour daytime or nighttime BP.
Most of the episodic CH patients (23/33, 69.7%) had a pABI, and the overall prevalence of low ABI was 27.7% (9/33). Abnormal ABI values showed no correlation with age, nocturnal BP pattern, structural parameters, and laboratory parameters (except for TG). The main clinical characteristics of the 33 patients and the comparative analysis based on ABI values are summarized in Table  3 . In the control group, 40.9% presented a pathological ABI (P ¼ 0.034).
IMT values above the 90th and 95th percentiles differed significantly between the episodic CH and control groups (25% vs 4.54%, P ¼ 0.012, and 20.8% vs 4.54%, P ¼ 0.015, respectively 16 .74 mmol/L), and were more likely to be nondippers (78.6% vs 30%, 83% vs 50%). As for other characteristics, there was no significant difference. These data are shown in Table 4 .
Discussion
To date, the association between CH and CRF remains unclear. We hypothesized that patients with CH or migraine (particularly with aura) would present an increased risk of cardiovascular disease [18] . To assess this possible association, we examined the relationship between CH and the presence of vascular and inflammatory biomarkers. According to diagnostic criteria, ABI values of 0.9 or less indicate the presence of PAD, which is associated with the presence of coronary heart disease and its progression. In addition, ABI values of 1.29 or greater are associated with a higher mortality rate. In our sample, nearly 70% of the CH patients presented abnormal ABI values (either <0.9 or >1.29), with nine of the 33 patients presenting an ABI of less than 0.9. These findings suggest a higher cardiovascular risk in CH patients. Except for TG, there were no statistically significant differences (t test) in laboratory and structural parameters between patients with normal or pathological ABI values and the BP pattern was similar in both groups.
Alterations in vascular structure, including increased wall thickness (IMT values), are increasingly recognized as a significant independent predictor of adverse cardiovascular outcomes [15] . In our sample, 25% of the patients were in the 90th percentile of these values and nearly 20% were in the 95th percentile. Overweight (BMI 25 kg/m 2 ) subjects (but not obese patients) had greater carotid IMT.
The increased risk of CVD in female migraine patients has been previously examined [18, 19] , although less is known about this possible association between CH and CVD in men [20] [21] [22] . Cirillo et al. found a greater prevalence for cigarette smoking and a lower prevalence for hypercholesterolemia among men with CH. Compared with data for a population sample used as control, patients with headache had higher prevalence of hypertension in both sexes [20] . Loder reviewed the available data on the association between CH and the heart, finding that disturbances of autonomic function or certain structural cardiac anomalies may be more common in CH sufferers [21] . Recently, Zidverc-Trajkovic et al. demonstrated that diabetes mellitus, considering gender, age, and duration of headache, was more frequently associated with CH than with migraine [22] .
We analyzed not only the BP pattern, but also laboratory and structural parameters to determine whether cardiovascular risk also appears to be combined with CH as occurs in migraine. We found a higher prevalence of the nondipper pattern and pathological ABI. Furthermore, we have found that a high percentage of CH patients present IMT values above 75th percentile. BMI is higher in patients with CH, although we believe that the slight difference in BMI values between patients and controls is not, by itself, likely to cause an increased incidence of nondipping or worse ABI or IMT values. These results are consistent with our initial hypothesis that patients with CH are at increased risk of CVD. To our knowledge, this is the first study to evaluate this possible association. Even though these data suggest that the presence of CH is associated with an increased risk of CVD, these findings must be interpreted cautiously because of the small sample size. Larger studies are needed to confirm the findings presented here.
Conclusions
This study reveals that, compared with healthy controls, a higher percentage of patients with CH have IMT values above 75th percentile. In addition, a high percentage of CH patients present a pathological ABI. These findings, together with the higher than expected rate of nocturnal nondipping, strongly suggest that patients with CH have a higher risk of developing cardiovascular disease than healthy subjects. As there is a difference in BMI values between groups, caution should be exercised in interpreting the results.
